(Q39553118)

13 September 2017

1 reference

title

Continuous infusion of low-dose doxorubicin, epirubicin and mitoxantrone in cancer chemotherapy: a review (English)

1 reference

13 September 2017

1 reference

Greidanus J

1

1 reference

13 September 2017

Willemse PH

2

1 reference

13 September 2017

Uges DR

3

1 reference

13 September 2017

Oremus ET

4

1 reference

13 September 2017

De Langen ZJ

5

1 reference

13 September 2017

De Vries EG

6

1 reference

13 September 2017

1 December 1988

1 reference

Pharmaceutisch weekblad. Scientific edition

13 September 2017

1 reference

13 September 2017

10

1 reference

13 September 2017

6

1 reference

13 September 2017

237-245

1 reference

Continuous Infusion or Bolus Injection in Cancer Chemotherapy

13 September 2017

1 reference

https://api.crossref.org/works/10.1007%2FBF02219662

Solitary bone lesions in two healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02219662

Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02219662

Antitumour activity and plasma kinetics of bleomycin by continuous and intermittent administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02219662

Reduced cardiotoxicity of doxorubicin delivered on a weekly schedule. Assessment by endomyocardial biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02219662

Mitoxantrone: a new anticancer drug with significant clinical activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02219662

4′-epi-doxorubicin, a new analogue of doxorubicin: a preliminary overview of preclinical and clinical data

21 January 2018

1 reference

12 December 2020

Activity of adriamycin in metastatic breast cancer resistant to a combination regimen with cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prdnisone

1 reference

12 December 2020

Optimal schedule for anthracyclines

1 reference

12 December 2020

Complications and management of implanted venous access catheters

1 reference

12 December 2020

A prospective randomized comparison of epirubicin and doxorubicin in patients with advanced breast cancer

1 reference

12 December 2020

Distribution and antitumor activity of adriamycin given in a high-dose and a repeated low-dose schedule to mice

1 reference

12 December 2020

A patient education program for a continuous infusion regimen on an outpatient basis

1 reference

12 December 2020

Subclavian vein thrombosis in patients treated with infusion chemotherapy for advanced malignancy

1 reference

12 December 2020

Mitoxantrone (novantrone): a review of experimental and early clinical studies

1 reference

12 December 2020

Clinical pharmacokinetics (second of two parts).

1 reference

12 December 2020

A programmable and implantable pumping system for systemic chemotherapy: a performance analysis in 52 patients

1 reference

12 December 2020

Multifactorial drug resistance in an adriamycin-resistant human small cell lung carcinoma cell line

1 reference

12 December 2020

Phase I study of protracted venous infusion of 5-fluorouracil

1 reference

12 December 2020

Adriamycin versus epirubicin in advanced soft tissue sarcomas. A randomized phase II/phase III study of the EORTC Soft Tissue and Bone Sarcoma Group

1 reference

12 December 2020

Improved therapeutic index of bleomycin when administered by continuous infusion in mice

1 reference

12 December 2020

Phase I study of cis-diamminedichloroplatinum(II) administered as a constant 5-day infusion

1 reference

12 December 2020

Adriamycin (NSC-123,127): a new antibiotic with antitumor activity

1 reference

12 December 2020

Pharmacokinetics of 4'-epi-doxorubicin in man

1 reference

12 December 2020

Clinical evaluation of long-term, continuous-infusion doxorubicin

1 reference

12 December 2020

Improved methods for venous access: the Port-A-Cath, a totally implanted catheter system

1 reference

12 December 2020

Effect of adriamycin on the cell cycle traverse and kinetics of cultured human lymphoblasts

1 reference

12 December 2020

Phase II evaluation of 4'-epi-doxorubicin in patients with metastatic colorectal carcinoma

1 reference

12 December 2020

Pharmacokinetics and metabolism of adriamycin in man

1 reference

12 December 2020

Adriamycin chemotherapy--efficacy, safety, and pharmacologic basis of an intermittent single high-dosage schedule.

1 reference

12 December 2020

Fifty-five patient years' experience with a totally implanted system for intravenous chemotherapy

1 reference

12 December 2020

Clinical assessment of the structure-activity relationship of anthracyclines and related synthetic derivatives

1 reference

12 December 2020

Increased relative effectiveness of doxorubicin against slowly proliferating sarcoma 180 cells after prolonged drug exposure

1 reference

12 December 2020

Constant infusion schedule for adriamycin: a phase I-II clinical trial of a 30-day schedule by ambulatory pump delivery system

1 reference

12 December 2020

Adriamycin given as a weekly schedule without a loading course: clinically effective with reduced incidence of cardiotoxicity

1 reference

12 December 2020

Phase II study of a 21-day continuous infusion schedule with epirubicin in metastatic colorectal cancer

1 reference

12 December 2020

Comparative pharmacokinetics and metabolism of doxorubicin and epirubicin in patients with metastatic breast cancer

1 reference

12 December 2020

A phase I and pharmacokinetic study with 21-day continuous infusion of epirubicin

1 reference

12 December 2020

Phase II study of weekly low-dose 4'-epi-doxorubicin in advanced postmenopausal breast cancer

1 reference

12 December 2020

Biliary excretion and pharmacokinetics of 4'epidoxorubicin (epirubicin) in advanced cancer patients

1 reference

12 December 2020

Evaluation of a totally implanted venous access port and portable pump in a continuous chemotherapy infusion schedule on an outpatient basis

1 reference

12 December 2020

1 reference

12 December 2020

The delivery of cancer chemotherapy by constant venous infusion. Ambulatory management of venous access and portable pump

1 reference

12 December 2020

Mitoxantrone: an overview of safety and toxicity

1 reference

12 December 2020

Cytocidal Action of Anticancer Agents : Evaluation of the Sensitivity of Cultured Animal and Human Cancer Cells

1 reference

12 December 2020

Phase I trial of mitoxantrone by 24-hour continuous infusion

1 reference

12 December 2020

Drug extravasation as a complication of venous access ports

1 reference

12 December 2020

Drug resistance in cancer

1 reference

12 December 2020

Adriamycin therapy by continuous intravenous infusion in patients with metastatic breast cancer

1 reference

12 December 2020

Prospective study of the pulmonary toxicity of continuously infused bleomycin

1 reference

12 December 2020

The role of anthracyclines in the treatment of gastric cancer

1 reference

12 December 2020

Drug therapy. Clinical Pharmacokinetics (first of two parts).

1 reference

12 December 2020

Continuous infusion chemotherapy: a critical review

1 reference

12 December 2020

Metabolism of 4'-modified analogs of doxorubicin. unique glucuronidation pathway for 4'-epidoxorubicin

1 reference

12 December 2020

The anthracycline antineoplastic drugs

1 reference

12 December 2020

Anthracycline analogs: the past, present, and future

1 reference

12 December 2020

Epirubicin in colorectal cancer. A phase II study of the early clinical trials group (EORTC)

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02219662

1 reference

13 September 2017

1 reference